- Home
- CADL vs WEYS Comparison
CADL vs WEYS Comparison
Compare CADL & WEYS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CADL
- WEYS
- Stock Information
- Founded
- CADL 1999
- WEYS 1906
- Country
- CADL United States
- WEYS United States
- Employees
- CADL N/A
- WEYS N/A
- Industry
- CADL Biotechnology: Pharmaceutical Preparations
- WEYS Apparel
- Sector
- CADL Health Care
- WEYS Consumer Staples
- Exchange
- CADL Nasdaq
- WEYS Nasdaq
- Market Cap
- CADL 306.4M
- WEYS 341.7M
- IPO Year
- CADL 2021
- WEYS N/A
- Fundamental
- Price
- CADL $4.57
- WEYS $28.97
- Analyst Decision
- CADL Strong Buy
- WEYS
- Analyst Count
- CADL 4
- WEYS 0
- Target Price
- CADL $21.00
- WEYS N/A
- AVG Volume (30 Days)
- CADL 1.1M
- WEYS 17.1K
- Earning Date
- CADL 05-13-2025
- WEYS 05-06-2025
- Dividend Yield
- CADL N/A
- WEYS 10.54%
- EPS Growth
- CADL N/A
- WEYS N/A
- EPS
- CADL N/A
- WEYS 3.16
- Revenue
- CADL N/A
- WEYS $290,290,000.00
- Revenue This Year
- CADL N/A
- WEYS N/A
- Revenue Next Year
- CADL N/A
- WEYS N/A
- P/E Ratio
- CADL N/A
- WEYS $9.17
- Revenue Growth
- CADL N/A
- WEYS N/A
- 52 Week Low
- CADL $3.79
- WEYS $25.51
- 52 Week High
- CADL $14.60
- WEYS $41.05
- Technical
- Relative Strength Index (RSI)
- CADL 32.96
- WEYS 45.07
- Support Level
- CADL $4.25
- WEYS $27.94
- Resistance Level
- CADL $5.33
- WEYS $32.00
- Average True Range (ATR)
- CADL 0.47
- WEYS 1.60
- MACD
- CADL -0.01
- WEYS 0.16
- Stochastic Oscillator
- CADL 19.45
- WEYS 53.31
About CADL Candel Therapeutics Inc.
Candel Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing viral immunotherapies to help patients fight cancer. The company has established two clinical-stage viral immunotherapy platforms based on novel, genetically modified adenovirus and herpes simplex virus (HSV) constructs, respectively.
About WEYS Weyco Group Inc.
Weyco Group Inc is a company, engaged in the manufacturing, designing, and distribution of footwear. The company designs and markets footwear for men, women, and children. It markets its apparel, accessories, and footwear under the brand names of Florsheim, Nunn Bush, Stacy Adams, BOGS, Rafters, and Forsake. The company organizes its business into two segments; the North American wholesale and the North American retail segment. The majority of the company's revenue is generated from the wholesale segment under which its products are sold to footwear, department, and specialty stores, as well as e-commerce retailers. The company has operational footprints in the United States which generates key revenue, Canada, Asia, South Africa, and Australia.